NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹189 Cr | ₹122 Cr | ₹147 Cr | ₹180 Cr | ₹170 Cr |
What is the latest Total Non-Current Liabilities ratio of NEULAND LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹189 Cr |
| Mar2024 | ₹122 Cr |
| Mar2023 | ₹147 Cr |
| Mar2022 | ₹180 Cr |
| Mar2021 | ₹170 Cr |
How is Total Non-Current Liabilities of NEULAND LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹189 Cr | 55.02 | |
| Mar2024 | ₹122 Cr | -16.73 | |
| Mar2023 | ₹147 Cr | -18.42 | |
| Mar2022 | ₹180 Cr | 5.90 | |
| Mar2021 | ₹170 Cr | - | |
Compare Total Non-Current Liabilities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹15,672.1 Cr | -3.7% | -7.8% | 4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,693.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,270.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,281.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,422.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹104,915.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -3.7% |
-7.8% |
4% |
| SENSEX | -2.7% |
-10.4% |
1.6% |
You may also like the below Video Courses